Pharmafile Logo
Pharmafocus logo
Advanced Search
psm_v46_d168_mesial_view_of_the_human_brain

Commonly used heart and diabetes drugs may improve mental health, study finds

January 10, 2019
Research and Development UCL, bipolar, mental health, research, schizophrenia

Commonly used anti-cholesterol drugs, blood pressure drugs and medicines used for diabetes may improve the mental health of those with …

News
bonecells

Amgen and UCB’s Evenity approved in Japan for osteoporosis

January 9, 2019
Research and Development, Sales and Marketing Amgen, Japan, UCB Pharma, osteoporosis, pharma

Amgen has revealed that its bone-forming monoclonal antibody Evenity (romosozumab), developed in partnership with UCB Pharma, has been awarded approval …

News

Death row inmate whose execution was postponed found dead in cell

January 9, 2019
Research and Development Alvogen, Scott Dozier, execution, pharma, prison

Scott Dozier, the death row inmate whose execution was stalled by court cases launched by pharmaceutical companies, has been found …

News

Super gonorrhoea on the rise, health officials warn

January 9, 2019
Research and Development STI, gonorrehoea, health, public health, std

Health officials from Public Health England (PHE) have warned that cases of antibiotic resistant strains of the sexually transmitted infection …

News

Pfizer to shutter two manufacturing plants in India, 1,700 jobs at risk

January 9, 2019
Manufacturing and Production, Research and Development India, Pfizer, pharma

Pfizer has announced it is to shut down two of its manufacturing facilities in India – a move which could …

News
clostridium_difficile_cdc

Researchers explain link between anti-inflammatories and C. difficile

January 9, 2019
Research and Development C diff, C.Diff, Vanderbilt, anti-inflammatory, cdi, nsaids, research

In the past, observational studies have found a link between the use of common nonsteroidal anti-inflammatory drugs (NSAIDs) and increased …

News
nicola_redfern

bluebird bio reveals new UK General Manager

January 9, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bluebird Bio, appointment, pharma

bluebird bio, a US-based gene therapy biotech with a focus on cancer and severe genetic conditions,  has named Nicola Redfern …

Appointment
jose_baselga

AstraZeneca hire controversial cancer doc to head new Oncology R&D unit

January 8, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, journal, oncology

The Anglo-Swedish multinational AstraZeneca has named Dr José Baselga as the firm’s new head of research and development in oncology.The …

Appointment
heart-2372134_640

Two biomarkers can aid in atrial fibrillation screening, researchers find

January 8, 2019
Manufacturing and Production, Research and Development University of Birmingham, atrial fibrillation, biomarkers, pharma

A team of researchers at the University of Birmingham has identified a pair of biomarkers which it says could aid …

News

Government unveils £20bn plan to revitalise NHS in England

January 8, 2019
Manufacturing and Production NHS funding, NHS< funding, brexit, government, health, policy

Theresa May and the chief executive of NHS England, Simon Stevens, have announced a new ten year plan for the …

News
takeda_global_hq

Takeda completes Shire acquisition

January 8, 2019
Manufacturing and Production M&A, MA, Shire, Takeda, acquisition, deal, pharma

Japanese firm Takeda Pharmaceuticals has successfully completed its acquisition of Shire Plc. The long anticipated deal has propelled the firm …

News
abbvie_0

AbbVie records an estimated $4billion in impairment charges after failure of cancer drug Rova-T

January 8, 2019
Manufacturing and Production AbbVie, M&A, MA, Stemcentrx, acquisition, rova-t

US firm AbbVie has said that it will record an estimated $4 billion in impairment charges related to the abandonment …

News
jallal

Immunocore names AstraZeneca exec as new CEO

January 7, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Clinical stage biotechnology company Immunocore has announced the appointment of AstraZeneca executive Bahija Jallal as the company’s new CEO. The …

Appointment
mark_mallon

Ironwood Pharmaceuticals names AstraZeneca veteran Mark Mallon as new CEO

January 7, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, CEO, Ironwood, Sweden, mark mallon

The Cambridge, Massachusetts pharma firm Ironwood Pharmaceuticals has announced the appointment of AstraZeneca veteran Mark Mallon in preparation for the …

Appointment
lilly_building_with_american_flag_web

Eli Lilly to buy Loxo Oncology in deal worth $8 billion

January 7, 2019
Manufacturing and Production Cancer, Eli Lilly, Loxo Oncology, gene therapy, personalised medicine

US firm Eli Lilly & Co today announced a definitive agreement for the acquisition of Connecticut-based company Loxo Oncology in …

News
cancer-vs-alzheimer-1080x810

Roche’s Genentech inks potential $2bn personalised cancer drug development deal

January 7, 2019
Sales and Marketing Adaptive Biotechnologies, Cancer, Genentech, Roche, oncology, pharma

Roche’s Genentech is set to enter into a deal with Adaptive Biotechnologies to bolster its pursuits in the treatment of …

News

How tech is powering precision treatment

January 7, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Precision Medicine, pharma, tech

As the scientific community eschews scattergun approaches and demand rises for higher-quality, targeted care, Matt Fellows explores how technologies such …

Feature
shutterstock_36423250

Promising interim Phase 3 data spurs epidermolysis bullosa trial expansion for Amryt

January 7, 2019
Research and Development, Sales and Marketing Amryt, epidermolysis bullosa, pharma, rare disease

Rare disease firm Amryt has announced interim efficacy data for its epidermolysis bullosa (EB) therapy AP101, showing that things are …

News
astrazeneca_plaque

AstraZeneca loses two senior executives as biotechs appoint new CEOs

January 7, 2019
Sales and Marketing AstraZeneca, CEO, Ironwood Pharmaceuticals, biotech, immunocore

Two of AstraZeneca’s senior executives have been poached by the biotech firms Ironwood Pharmaceuticals and Immunocore, as the two biotechnology …

News

$400 billion in healthcare M&A deals expected for 2019

January 7, 2019
Sales and Marketing Hong Kong, M&A, MA, biotech, deals pharma, law, mergers

The coming year is set to see mergers and acquisitions in the healthcare sector worth more than $400 billion, according …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026